Editorial

Robert Detrano, MD, PhD
Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, Los Angeles

Address: Robert Detrano, MD, PhD, Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, 1124 West Carson Street, Torrance, CA 90502

Robert Detrano, MD, PhD
Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, Los Angeles

Address: Robert Detrano, MD, PhD, Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, 1124 West Carson Street, Torrance, CA 90502

Robert Detrano, MD, PhD
Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, Los Angeles

Address: Robert Detrano, MD, PhD, Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, 1124 West Carson Street, Torrance, CA 90502

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center; Director, Cardiology Fellowship Training Program; Co-Director, UCLA Preventive Cardiology Program; Associate Professor of Medicine, UCLA Division of Cardiology, Los Angeles

Address: Gregg C. Fonarow, MD, Ahmanson-University of California Los Angeles Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679; e-mail: gfonarow@mednet.ucla.edu

The author has indicated that he has received grant or research support from the Bristol-Myers Squibb, Merck, Merck-Schering Plough, and Pfizer corporations, and that he serves as a consultant and is on the speakers’ bureaus of the same corporations.

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center; Director, Cardiology Fellowship Training Program; Co-Director, UCLA Preventive Cardiology Program; Associate Professor of Medicine, UCLA Division of Cardiology, Los Angeles

Address: Gregg C. Fonarow, MD, Ahmanson-University of California Los Angeles Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679; e-mail: gfonarow@mednet.ucla.edu

The author has indicated that he has received grant or research support from the Bristol-Myers Squibb, Merck, Merck-Schering Plough, and Pfizer corporations, and that he serves as a consultant and is on the speakers’ bureaus of the same corporations.

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center; Director, Cardiology Fellowship Training Program; Co-Director, UCLA Preventive Cardiology Program; Associate Professor of Medicine, UCLA Division of Cardiology, Los Angeles

Address: Gregg C. Fonarow, MD, Ahmanson-University of California Los Angeles Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679; e-mail: gfonarow@mednet.ucla.edu

The author has indicated that he has received grant or research support from the Bristol-Myers Squibb, Merck, Merck-Schering Plough, and Pfizer corporations, and that he serves as a consultant and is on the speakers’ bureaus of the same corporations.

Garabed Eknoyan, MD
Renal Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Garabed Eknoyan, MD, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030; e-mail: geknoyan@bcm.tmc.edu

Garabed Eknoyan, MD
Renal Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Garabed Eknoyan, MD, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030; e-mail: geknoyan@bcm.tmc.edu

Garabed Eknoyan, MD
Renal Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Garabed Eknoyan, MD, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030; e-mail: geknoyan@bcm.tmc.edu

Charles S. Modlin, MD
Urological Institute, Section of Renal Transplantation, The Cleveland Clinic

Address: Charles S. Modlin, MD, Urological Institute, A100, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: modlinc@ccf.org

Charles S. Modlin, MD
Urological Institute, Section of Renal Transplantation, The Cleveland Clinic

Address: Charles S. Modlin, MD, Urological Institute, A100, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: modlinc@ccf.org

Charles S. Modlin, MD
Urological Institute, Section of Renal Transplantation, The Cleveland Clinic

Address: Charles S. Modlin, MD, Urological Institute, A100, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: modlinc@ccf.org

Roger M. Mills, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Roger M. Mills, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: millsr@ccf.org

Roger M. Mills, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Roger M. Mills, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: millsr@ccf.org

Roger M. Mills, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Roger M. Mills, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: millsr@ccf.org

Eric A. Klein, MD
Head, Section of Urologic Oncology, Urological Institute, The Cleveland Clinic; National Study Coordinator, Selenium and Vitamin E Cancer Prevention Trial

Address: Eric A. Klein, MD, Department of Urology, A100, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Eric A. Klein, MD
Head, Section of Urologic Oncology, Urological Institute, The Cleveland Clinic; National Study Coordinator, Selenium and Vitamin E Cancer Prevention Trial

Address: Eric A. Klein, MD, Department of Urology, A100, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Eric A. Klein, MD
Head, Section of Urologic Oncology, Urological Institute, The Cleveland Clinic; National Study Coordinator, Selenium and Vitamin E Cancer Prevention Trial

Address: Eric A. Klein, MD, Department of Urology, A100, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195